LU Ruixia, ZHU Xiaoxing, ZHANG Min, et al. Discussion on Pathogenic Toxin and the Syndromes and Treatment of Coronary Heart Disease[J]. Journal of Traditional Chinese Medicine2020, 61(1): 27-30.
LU Ruixia, ZHU Xiaoxing, ZHANG Min, et al. Discussion on Pathogenic Toxin and the Syndromes and Treatment of Coronary Heart Disease[J]. Journal of Traditional Chinese Medicine2020, 61(1): 27-30.DOI: 10.13288/j.11-2166/r.2020.01.007.
Discussion on Pathogenic Toxin and the Syndromes and Treatment of Coronary Heart Disease
There are multiple meanings for "toxin" in Chinese medicine
which can be divided into endogenous toxin and exogenous toxin as causes of disease. Toxin plays an important role in the occurrence and development of coronary heart disease. The toxin of coronary heart disease is endogenous
which is an important pathological factor accompanying the development of coronary heart disease and a decisive factor in the formation of unstable lesions. The toxin of coronary heart disease is the toxin from blood stasis of vital qi
which can be divided into apparent toxin and hidden toxin according to the different clinical manifestations. The former includes obvious clinical symptoms
while the latter has no or only a small amount of physical and chemical indexes such as high sensitivity C-reactive protein abnormalities. Strengthening body resistance for removing toxins is the basic treatment principle of coronary heart disease. The clinical treatment should be based on the differentiation of diseases and differentiation of syndrome combined with different pathological factors of blood stasis
Analysis of Clinical and Phenomics Characteristics of Patients with Phlegm-Stasis Binding Syndrome and Its Accompanied Patterns in Stable Angina Pectoris of Coronary Heart Disease
Pathogenesis Evolution and Staged Differentiation and Treatment Strategy of Atherosclerotic Plaques:from the Perspective of "Constraint-Putrefaction-Ulceration"
Effects of Yangxin Tongmai Formula (养心通脉方) on Methylation Key Genes and the PERK/ATF4/CHOP Signaling Pathway in Myocardial Tissue of Coronary Heart Disease Model Rats with Blood Stasis Syndrome
Construction of a Diagnostic Model for Coronary Heart Disease with Blood Stasis Syndrome Based on Objective Multi-Modal Data Fusion
Expert Consensus on the Clinical Application of Jiuxin Pills (救心丸) in the Treatment of Coronary Heart Disease
Related Author
LI Chongchai
LI Han
LI Zheng
LI Zeng
ZHOU Yushi
AO Yuhan
XU Shuang
WANG Xue
Related Institution
Liaoning University of Traditional Chinese Medicine
Shenyang Health Service Center
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Clinical Evaluation Center,China Academy of Chinese Medical Sciences
Dongfang Hospital,Beijing University of Chinese Medicine